TLR2 and neoplasm: The naïve cohorts of CC-LR/TLR2, 4, and 9 mice also showed 1.7-fold (35 vs 60), 1.5-fold (40 vs. 60), and 2-fold (30 vs. 60) reductions in tumor numbers respectively compared to age and sex match naïve CC-LR mice (Supplementary Figure S1).